分化型甲状腺癌患者经SPECT/CT诊断的胡须131I污染
Beard Contamination With 131 I Diagnosed by SPECT/CT in a Patient With Differentiated Thyroid Cancer.
PubMed 文献 · Clin Nucl Med · 2024-05-14
一例32岁分化型甲状腺癌男性患者行甲状腺残余组织放射性碘消融治疗后,平面全身扫描显示颈部侧面局灶性131I浓聚,经颈部SPECT/CT证实放射性活性位于患者胡须,为假阳性摄取。
要点
- 分化型甲状腺癌患者131I治疗后平面显像见颈部侧面局灶性浓聚时,需考虑污染所致假阳性。
- SPECT/CT可帮助明确131I局灶性摄取的解剖定位,本例定位于胡须。
- 颈部侧面异常131I浓聚并非总提示转移,胡须污染是可能的假阳性原因之一。
核心结论
- 分化型甲状腺癌患者131I治疗后平面全身扫描发现的颈部侧面局灶性浓聚,经SPECT/CT证实为胡须131I污染所致假阳性。
研究设计与样本
- 病例报告:一例32岁男性分化型甲状腺癌患者,行甲状腺残余组织放射性碘消融治疗后进行平面全身扫描及颈部SPECT/CT显像。
主要发现
- 治疗后平面全身扫描显示颈部侧面投射区可见明显131I摄取。
- 颈部SPECT/CT扫描将放射性活性定位于患者胡须。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Abnormal focal accumulation of 131 I is generally a reliable indicator of differentiated thyroid cancer metastases. However, many examples of false-positive 131 I uptake were reported, some of them of unusual nature. We report a case of 32-year-old man with differentiated thyroid cancer who underwent thyroid remnants ablation with radioiodine. An area of considerable 131 I uptake projecting onto lateral cervical areas was detected on posttherapy planar whole-body scan. Neck SPECT/CT scan was done to elucidate localization of the uptake, and activity was found in the patient's beard.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Makarewicz J, Rudzki J. Beard Contamination With 131 I Diagnosed by SPECT/CT in a Patient With Differentiated Thyroid Cancer. Clin Nucl Med. 2024. PMID: 38768062. doi:10.1097/RLU.0000000000005282
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。